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Discerning the structural building blocks of macro-
molecules is essential for understanding their folding
and function. For a new generation of modified nu-
cleic acid ligands (called slow off-rate modified ap-
tamers or SOMAmers), we previously observed
essential functions of hydrophobic aromatic side
chains in the context of well-known nucleic acid mo-
tifs. Here we report a 2.45-A˚ resolution crystal struc-
ture of a SOMAmer complexed with nerve growth
factor that lacks any known nucleic acid motifs,
instead adopting a configuration akin to a triangular
prism. The SOMAmer utilizes extensive hydrophobic
stacking interactions, non-canonical base pairing
and irregular purine glycosidic bond angles to adopt
a completely non-helical, compact S-shaped struc-
ture. Aromatic side chains contribute to folding by
creating an unprecedented intercalating zipper-like
motif and a prominent hydrophobic core. The struc-
ture provides compelling rationale for potent inhibi-
tory activity of the SOMAmer and adds entirely novel
motifs to the repertoire of structural elements
uniquely available to SOMAmers.
INTRODUCTION
The in vitro process of SELEX (systematic evolution of ligands by
exponential enrichment) has been used extensively to identify
nucleic acid ligands to biological targets of interest. However,
given the inherent limitations of natural nucleotides, certain tar-
gets remained refractory to traditional SELEX methods. The
use of modified nucleotides with enhanced chemical diversity
has dramatically increased the success rate of SELEX (Gold
et al., 2010; Vaught et al., 2010). Such chemically modified ap-Structure 23, 1tamers are particularly well-suited to selection schemes that
favor long-lived complexes; hence, we refer to this class of ap-
tamers as SOMAmers (slow off-rate modified aptamers).
SOMAmers have transformed the landscape of proteomics,
leading to a sensitive and highly multiplexed platform with appli-
cations in biomarker discovery and early-stage disease detec-
tion (De Groote et al., 2013; Gold et al., 2010, 2012; Loffredo
et al., 2013; Lollo et al., 2014; Mehan et al., 2012, 2013; Ostroff
et al., 2010, 2012), as well as sandwich-based single analyte
detection assays (Ochsner et al., 2013, 2014), rapid histochem-
istry tools (Gupta et al., 2011), and therapeutic applications (Gel-
inas et al., 2014; Gupta et al., 2014).
Herein we describe a SOMAmer that binds and neutralizes
beta nerve growth factor (NGF), a member of the neurotrophin
family of secreted proteins critical for development and mainte-
nance of the nervous system in mammals. NGF functions as an
important mediator of itching, pain, and inflammation, and inhibi-
tion of NGF-mediated signaling has been explored as a treat-
ment for a variety of disorders including neuropathic pain, noci-
ceptive pain, osteoarthritis pain, and fibromyalgia (Ghilardi et al.,
2011; Hefti et al., 2006; McKelvey et al., 2013). NGF binds two
cell surface receptors, tropomyosin receptor kinase (TrkA) and
p75 neurotrophin receptor (p75NTR), a member of the tumor ne-
crosis family of receptors. NGF binding to TrkA stimulates auto-
phosphorylation and consequent signal transduction via the
mitogen-activated protein kinase and phosphatidylinositol
3-kinase pathways, promoting neuronal survival and/or differen-
tiation. NGF binding to p75NTR potentiates TrkA signaling (Ceni
et al., 2010; Eibl et al., 2012). Several structures of NGF, apo
and receptor bound, have been published (He and Garcia,
2004; McDonald et al., 1991; Wehrman et al., 2007; Wiesmann
et al., 1999). The active form of NGF is a non-covalent homo-
dimer with tightly associated monomers that fold into a pair of
b-pleated strands, with four intervening loop regions (Bothwell
and Shooter, 1977).
NGF has been a SELEX target in the past, with the aptamers
identified as having either relatively weak binding affinity
(Kd 200 nM) (Binkley et al., 1995) or requiring long sequences293–1304, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1293
Figure 1. Short NGF SOMAmers Potently
Inhibit NGF Activity In Vitro
(A) Key elements of the random DNA SELEX li-
brary, including the random region (comprising
dA, dC, dG, and Bn-dU nucleotides) and the 50 and
30 fixed regions for primer binding.
(B) Structure of 5-(N-benzylcarboxamide)-20-de-
oxyuridine (Bn-dU).
(C) Sequences and binding affinities of SL1047
and its truncated variants. 50 and 30 fixed region
sequences are represented by ‘‘. ’’ and Kd values
are reported as the mean ± SD of three replicate
measurements.
(D) Effect of NGF SOMAmer on neurite outgrowth
of PC12 cells stimulated by NGF. Cultured PC12
cells were treated for 5 days with or without NGF
(0.38 nM) or NGF pre-equilibrated with test article
(10 nM). Cells were photographed and neurite
length was measured using the NeuronJ plugin for
ImageJ.
(E) Neurite length plotted relative to that observed
in the absence of added SOMAmer.
(F) Dose-response of NGF SOMAmers SL1047
and SL1049 on neurite outgrowth. Each data point
represents the mean ± SD of three replicate
measurements at each SOMAmer concentration.
(G) Inhibition of NGF-induced TrkA phosphoryla-
tion by NGF SOMAmers. Cultured PC12 cells were
treated for 10 min with NGF (0.38 nM) or NGF pre-
equilibrated with test article (0.2 mM K252a or
10 nM oligonucleotide). Cell lysates were immuno-
precipitated with an anti-Trk antibody C-14 and
resolved with SDS-PAGE. Phosphorylated and
total TrkA were examined by anti-phospho-tyro-
sine antibody 4G10 and anti-Trk antibody C-14,
respectively. See also Figure S1.(>45 nucleotides) for high affinity binding (Nakamura et al., 2013).
Here, we describe the identification of a considerably shorter
SOMAmer that exhibits high affinity binding to NGF and potently
inhibits NGF-mediated TrkA phosphorylation and neurite
outgrowth in vitro.
To understand its mode of action, we solved the crystal struc-
ture of this SOMAmer bound to recombinant human NGF to
2.45-A˚ resolution. We have previously reported the co-crystal
structures of two SOMAmer-target complexes (Davies et al.,
2012; Gelinas et al., 2014). These structures revealed extensive
utilization of modified nucleotide side chains at the protein bind-
ing interface, serving to mimic native receptor interactions. The
resulting SOMAmer-protein binding surfaces exhibit more hy-1294 Structure 23, 1293–1304, July 7, 2015 ª2015 Elsevier Ltd All rights reserveddrophobic character and considerably
fewer polar interactions compared with
traditional aptamers (Davies et al.,
2012). Both structures utilized scaffolds
composed of familiar nucleic acid
structural motifs such as pseudoknots,
G-quartets, and hairpins, which were
augmented by modified nucleotides. In
the present work, we report the structure
of a third SOMAmer-target complex that
reveals a marked departure from previ-
ous observations and highlights theextraordinary structural plasticity afforded by selective chemical
modifications of natural nucleotides.
RESULTS
Identification of an NGF SOMAmer by SELEX
To identify a SOMAmer to NGF, we performed SELEX with a
modified DNA library containing the hydrophobic nucleotide 5-
(N-benzylcarboxamide)-20-deoxyuridine (Bn-dU) replacing dT
(Figures 1A and 1B). Following affinity screening, we chose
SL1047 for further analysis, one of the highest affinity
SOMAmers that belongs to a family of related sequences
comprising about 9% of the affinity-enriched pool (Figure S1A).
Table 1. Crystallographic Data Collection and Refinement
Statistics
Data Collection Native NaI Soak
Space group C2 C2
Unit-cell parameters:
a, b, c (A˚), b ()
109.20, 60.71,
68.59, 95.57
107.46, 60.60,
67.44, 95.78
Wavelength (A˚) 0.97950 1.54
Resolution range (A˚) 50.00–2.45
(2.00–2.45)
50.00–3.15
(3.23–3.15)
Unique reflections 15,532 14,556
Completeness (%) 98.2 (84.1) 99.3 (100)
Rmerge 0.038 (0.303) 0.101 (0.372)
Mean I/s (I) 23.3 (2.03) 10.92 (2.97)
Refinement Native N/A
Resolution range (A˚) 50.00–2.45
(2.51–2.45)
Rcryst 0.202 (0.380)
Rfree 0.257 (0.342)
RMSD bonds (A˚) 0.0134
RMSD angles () 2.112
Total no. of atoms 2,883
Wilson B factor (A˚2) 55.28
Mean B factor (A˚2),
all atoms
55.61
Mean B factor (A˚2), protein
atoms
53.92
Mean B factor (A˚2), nucleic
acid atoms
59.68
Error in coordinates by
Luzzati plot (A˚)
0.405
Disordered side chains 11
Residues in favored
regions (%)
175 (96.15)
Residues in disallowed
regions (%)
0 (0.00)
MolProbity score
(percentile)
2.12 (91st)
PDB code PDB: 4ZBN
Values in parentheses indicate the values for the highest of 20 resolution
shells.
Rmerge = ShSijIi(h)  <I(h)>j/ShSiIi(h).
Rfree = ShjjFobsj  jFcalcjj/ShjFobsj.
The free R factor was calculated using 5% of the reflections omitted from
the refinement (Collaborative Computational Project, Number 4, 1994).We determined the minimal sequence for SL1047 by
comparing the affinities of synthetic variants truncated system-
atically from the 50 and 30 ends. Several truncated variants
comprised of 25–28 nucleotides exhibited equal or better affinity
compared with the full-length sequence (Figure 1C). The full-
length SOMAmer (SL1047) and the 28-mer truncated variant
(SL1049) inhibited NGF-mediated neurite outgrowth in PC12
cells in vitro (Figures 1D and 1E) in a concentration-dependent
manner with half maximal inhibitory concentration values of
2 nM and 1 nM, respectively (Figure 1F). Shorter binding-
competent variants were less active (27-mer SL1051) or inactiveStructure 23, 1(26-mer SL1052 and 25-mer SL1053) (Figures 1C and 1E). The
reason for the lack of activity of these shorter variants is not clear
(even with the benefit of the structure; see below); we have
speculated these results could be due to structural rearrange-
ment of the SOMAmer, decreased stability of the SOMAmer
structure (or the complex), or less efficient binding in the cell me-
dium and assay conditions. The control sequence, SL1048, with
deletion of the 30 region essential for high affinity binding was
also inactive (Figures 1C and 1E). SL1047 and SL1049 at
10 nM also inhibited NGF-induced phosphorylation of TrkA to
the same degree as the small molecule tyrosine kinase inhibitor
K252a (Tapley et al., 1992) at 200 nM, while SL1048 showed
minimal inhibition (Figure 1G). SL1049 exhibited a relatively rapid
association rate (kon = 8.0 3 10
5 M1 s1) and slow dissociation
rate (koff = 2.53 10
4 s1; t1/2 = 46 min) (Figures S1B–S1D), with
a calculated Kd value of 0.3 nM, in close agreement with equilib-
rium measurements (Figure 1C). SL1049 was highly selective for
NGF, with more than 100-fold lower affinity to related neurotro-
phins NT3, NT4, and brain-derived neurotrophic factor (Fig-
ure S1E), and showed similar high affinity to human, mouse,
and rat NGF (Figure S1F).
Crystallization of SOMAmer-NGF Complexes
To gain insight into the mode of binding and inhibition by the
SOMAmer, we determined the crystal structure of SL1049 in a
complex with NGF. Size exclusion chromatography indicated
that SL1049 formed a complex with NGF in a 1:1 stoichiometry
(i.e., two SOMAmer molecules per NGF dimer; data not shown).
Initial sparse matrix screens for crystallization conditions pro-
duced crystal hits with the human NGF ortholog but not with
the mouse or rat orthologs. Native X-ray data were collected at
2.45-A˚ resolution and the structure was solved through a combi-
nation of molecular replacement and heavy atom phasing tech-
niques (Table 1; Figure S3).
Structure Overview
Two SOMAmers (chains D and E) bind to symmetrical sites at the
NGF dimer interface (chains A and B) (Figure 2A). The structure of
NGF protein within the co-crystal is globally similar to previously
published NGF structures (He and Garcia, 2004; Holland et al.,
1994; Wehrman et al., 2007; Wiesmann et al., 1999), although
the conformations of some loops and side chains are perturbed
by interactions with the SOMAmer. A few short loops are disor-
dered in the SOMAmer-bound structure, including Asn45-Asn46
and Pro61-Asp65, and Asp93-Gln96 (only disordered in chain
B). The only significant asymmetry in the dimeric crystal structure
is evident at the N terminus of NGF chain B and the C terminus of
chain A. Residues His4-Glu10 and Arg114 are ordered only in
chains B and A, respectively. This helix interacts with the 30 end
of SOMAmer chain E. The asymmetric model likely arises due to
a crystal contact between His4 on the NGF B chain and dC1 on
the SOMAmer E chain of a symmetry mate. The SOMAmer chain
D is virtually identical to chainE (root-mean-square [RMS]=0.315,
521 atoms), with the exception of the crystal contact mentioned
above and the extruded base, dG20. We focus on the SOMAmer
chain E in subsequent figures as it illuminates more protein con-
tacts with the N-terminal amino acids of NGF than chain D.
The SOMAmer adopts a compact S-shaped fold with a striking
absence of helicity (Figures 2B and 2C). The structure can be293–1304, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1295
Figure 2. SOMAmer Forms a Compact S-Shape and Binds NGF at the Dimer Interface
The NGF homodimer is represented as wheat (chain A) and gold (chain B) colored ribbons and the SOMAmer (chains D and E) is shown as a backbone trace with
the bases colored by strand. The strands are numbered from 50 to 30: strand 1 (slate blue; nucleotides 1–9), strand 2 (light purple, nucleotides 10–18), and strand 3
(purple, nucleotides 19–28). Modified nucleotides are colored red.
(A) The upper view shows the complex perpendicular to the non-crystallographic 2-fold axis of symmetry; the lower view is parallel to this 2-fold axis of symmetry,
viewed from the 50 end.
(B) Cartoon rendition of the SOMAmer, showing base-pairing and stacking interactions, with base pairs denoted according to the nomenclature of Leontis and
Westhof (2001).
(C) SOMAmer chain E, colored by strand with modified nucleotides colored red. See also Figure S2.divided into three strands delineated by tight backbone turns
with strands 1–3 (Str1–3) comprising nucleotides 1–9, 10–18,
and 19–28, respectively (Figures 2B and 2C). The SOMAmer
contains several secondary structure features that are common
in RNA but less common in previously observed DNA structures,
such as Hoogsteen base pairing, triple strand, and purine-phos-
phate interactions. Remarkably, the tightly folded structure
makes extensive use of non-canonical base pairs, with only
four Watson-Crick (WC) base pairs out of 17 total hydrogen
bond-mediated base-pairing interactions (Figures 2B and
S2C). Although the SOMAmer exhibits features suggestive of
an extremeH-type pseudoknot, it defies categorization into clas-
sical pseudoknot sub-elements (Figure 2C) and the complete
lack of helical twist renders the structure more reminiscent of
a triangular prism. Three major structural influences contribute
to the unconventional conformation adopted by the NGF
SOMAmer: (1) intercalation and edge-to-face p stacking of
modified nucleotides, (2) glycosidic bond conformations
including both syn and anti purines, and (3) non-canonical base
pairing, triple and quadruple bases, and base-to-backbone
hydrogen bonding.
Structural Motifs: Intercalating Zipper and Benzyl
Cluster
In a notable departure from previous SOMAmer structures,
most of the benzyl side chains of modified nucleotides in the1296 Structure 23, 1293–1304, July 7, 2015 ª2015 Elsevier Ltd All rigNGF SOMAmer (six of nine) do not contact the protein (Figures
3A–3F). Instead, these residues play a purely structural role,
supporting the unusual conformation of the nucleic acid scaf-
fold. At the 50 end, an intriguing motif is the intercalating zipper
formed by Bn-dU3 and Bn-dU16. The two Bn-dU nucleotides
exhibit an offset dyad symmetry, allowing the teeth of the
zipper to align based on reciprocal p-stacking of the benzyl
moiety from one side with the uridine from the opposite side
(Figures 3B, 3C, and S3A). Each benzyl ring (Bn) thereby effec-
tively acts as a pseudo base, covalently linked to uridine, taking
the place of a conventional hydrogen-bonded base pair. The
zipper is supported by an edge-to-face p-stacking interaction
with Bn18.
A second zipper-like motif is present in the benzyl cluster
comprising Bn-dU10, Bn-dU11 and Bn-dU27, where Bn-dU10
and Bn-dU27 actually mimic the Bn-dU3:Bn-dU16 intercalating
zipper, exhibiting the characteristic reciprocal stacking between
the benzyl and uridine moieties from opposing strands (Figures
3E, 3F, and S3B). However, rotational freedom in the linkers al-
lows both of the benzyl groups to twist, in apparent synchrony,
out of the plane of the base to allow face-to-face stacking with
the opposite uridine (Figures 3E and 3F). The non-planar nature
of these modified nucleotides creates three distinct p-stacking
systems, interconnected through Bn27. First, Bn11 stacks with
dC9 and interacts edge-to-face with Bn27 (Figures 3E and 3F).
Bn27 in turn intercalates between dU10 and dU11 (dU specifieshts reserved
Figure 3. Modified Nucleotides Are Integral to Both the Scaffold and the Protein Binding Interface
(A) The benzyl zipper is located near the 50 end of the SOMAmer and the Str2/Str3 turn.
(B) Zoomed in view of the Bn-dU3:Bn-dU16 zipper shows reciprocal p-stacking between uridines and benzyl moieties with additional aromatic interactions from
neighboring Bn-dU18. Bn-dU17 is extruded by the zipper, allowing it to make significant contact with NGF.
(C) Rotated view of the benzyl zipper highlights the continuous stacking that results from the intercalated Bn-dU nucleotides.
(D) The benzyl cluster is located near the 30 end of the SOMAmer and the Str1/Str2 turn.
(E) Zoomed in view of (D) shows the three p-stacking systems of the benzyl cluster, interconnected through Bn27. The dC9:dG28 base pair caps the benzyl
cluster and connects Str1/Str2 of the SOMAmer to the 30 end.
(F) Rotated view of the benzyl cluster. See also Figures S3 and S4.just the uridine base of a modified nucleotide) creating the sec-
ond aromatic stacking system (Figure 3E). The third system con-
tains a quadruple stacking arrangement including both
SOMAmer (dG28, Bn10, dU27) and NGF (Phe12) aromatic
groups (Figures 3F and 5D); Bn10 also makes an edge-to-edge
contact with Bn27 and an edge-to-face interaction with the
sugar ring of dG28. The dC9:dG28 base pair serves as a cap
for the hydrophobic benzyl cluster, protecting it from solvent
while the extensive network of aromatic interactions connects
the 30 end of the SOMAmer to the backbone turn between Str1
and Str2 (Figures 3D and 3E). Although the benzyl cluster is pri-
marily an internal structural motif where the benzyl side chains do
not interact with the protein, all three nucleotides do make con-
tact with NGF (Table S1).
Given the dual utilization of Bn-dU nucleotides at the protein
binding interface and as internal structural elements, we
wanted to determine the essential role of the benzyl groups
for the structure and function of the NGF SOMAmer. To that
end, we sequentially replaced each Bn-dU nucleotide with dT
and assessed the effect on binding affinity. We found that
only Bn-dU18 was dispensable within the SOMAmer, with allStructure 23, 1other substitutions resulting in significantly reduced binding af-
finities (from 6- to >100-fold) (Figure S2D). These results
confirmed the critical function of the Bn-dU nucleotides in form-
ing the unusual conformation that provides high affinity binding
to NGF.
An Unconventional Triple-Stranded Core
The central region of the SOMAmer consists of a triple strand
comprising dG4-dG7 (Str1), dG12-dG15 (Str2), and dC21-
dU24 (Str3) (Figure 4A). The triple-stranded region of the NGF
SOMAmer includes one base triple and three base quadruples
(Figures 4 and S5). In the dG4-dG15-dC21-dU17 base
quadruple (Figures 4B and S5A), dC21 forms five H bonds,
thereby exhibiting complete utilization of every available
H-bond donor and acceptor. The next base triple, dA5-dG14-
dC22 (Figure 4C) involves a WC base pair between dG14 and
dC22, and an unusual interaction between dG14 and dA5
involving at least one H bond between dG14 O6 and N6 of
dA5. A second H bond between dG14 and dA5 could poten-
tially occur if the adenosine is protonated at N1 (because its
pKa is raised by the local environment) or assumes the imino293–1304, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1297
Figure 4. Core Region Composed of Base Triples and Base Quadruples
(A) One base triple and three base quadruples are located in the central region of the SOMAmer.
(B) A base quadruple consisting of dG4-dG15-Bn-dU17-dC21 has eight H bonds with dC21 utilizing every available H-bond donor and acceptor.
(C) The base triple of dA5-dG14 and dC22. The interaction between dA5 and dG14 includes one H bond between dG14 O6 and N6 of dA5 and a second potential
H bond if dA5 adopts the imino tautomeric form with protonation of N1. The same type of H bond could be formed with dA5 protonated at N1.
(D) The dG6-dG13-dG23-dU24 base quadruple centered on dG13 exhibits nearly complete engagement of every available H-bond donor and acceptor. This
quadruple includes two base-to-backbone H bonds between the WC face of dG13 and a non-bridging oxygen at U24, and to a bridging oxygen at dG23.
(E) The base quadruple consisting of dG7-dG12-dU24-dU25 includes two H bonds between the base of dG12 and the backbone at dU24 and dU25.
The arrow in (A) indicates the zoomed in region of the SOMAmer. All additional arrows point to the region of the SOMAmer where the corresponding bases can be
seen. See also Figure S5.tautomeric form with a proton at N1 (Figures 4C and S5B).
dG6-dG13-dG23-dU24 form a base quadruple (Figures 4D
and S5C) centered on dG13, which exhibits nearly complete
engagement of every available H-bond donor and acceptor
via WC, Hoogsteen and sugar edge base pairing and base-
to-backbone interactions. In the final base quadruple, dG7-
dG12-dU24-dU25 (Figures 4E and S5D), dG12 makes a Hoogs-
teen base pair with dG7 and three atypical H bonds on its WC
face, one to the Bn-dU24 linker and the remaining two from
base to backbone. Overall, this core region comprises a dense
network of 24 H bonds. With additional stabilization contributed
by an extensive system of p-p stacking interactions (Figures
2B and 3A), the central core clearly represents an important
structural element in the folded organization of the SOMAmer.
Consistent with these observations, SL1049 exhibits a thermal
melting transition with a Tm value of 50
C, approximately 20C
higher than the unmodified DNA with the same sequence (Fig-
ures S4A and S4B). As observed previously with other
SOMAmers (Gupta et al., 2014), SL1049 is also substantially
more resistant to serum nucleases compared with its all-DNA
equivalent (Figures S4C and S4D), which is likely due, in part,
to its unusual structure.1298 Structure 23, 1293–1304, July 7, 2015 ª2015 Elsevier Ltd All rigProtein Recognition Domain Supported by a Flat Duplex
Scaffold
The overall structure of the SOMAmer can be viewed as a trian-
gular prism with the backbones of each strand defining the three
edges. Two sides (Str1 and Str2) serve as a scaffold, while the
third side (Str3) serves as the recognition domain for binding
NGF. A 180 backbone turn between Str1 and Str2 forms a
hairpin composed of almost entirely non-canonical base pairs
that create an extraordinarily flat duplex (stem I; Figure 2B).
Structurally, stem I benefits from contiguous stacking of multiple
elements, beginning with a Hoogsteen dA2-dU18 base pair,
which stacks with the intercalating zipper (Bn-dU3:Bn-dU16).
The zipper stacks with four purine-purine base pairs in the tri-
ple-stranded core. Stem I is completed by two cross-over
base pairs between Str1-Str3 (dA8-dU25) and Str2-Str3 (dU11-
dG26), respectively. Stem I forms a planar duplex characterized
by an almost non-existent minor groove and an extremely wide
major groove. This is achieved through a combination of non-ca-
nonical base pairing, intercalation of the modified nucleotides,
and unusual glycosidic bond conformations; more than half the
purines (6 of 11 in stem I, and 8 of 15 in the SOMAmer altogether)
adopt a syn conformation (Table S1). Between Str2 and Str3, thehts reserved
Figure 5. NGF-SOMAmer Binding Interface
(A) Str3 of the SOMAmer conforms to the NGF surface through atypical curvature of the backbone, contrary to Str1 and Str2, which form a relatively flat structure
distal to the binding interface.
(B) Bn17 sits in a hydrophobic pocket on the NGF surface, stacking face-to-face with Trp21 and edge-to-face with Tyr52. dG23 makes an H bond to the protein
backbone at Trp21, while dG22 makes an H bond to the side chain.
(C) The uridine base of Bn-dU24 makes five H bonds with NGF, two mediated by presumed water molecules at the interface. dU11 makes an H bond to Arg59
while Bn-dU25 stacks with the methylene side chain.
(D) Bn-dU27 forms a zipper-like motif with Bn-dU10 which stabilizes the 30 end of the SOMAmer. dU27 stacks with Phe12 on NGF and it also makes an H bond to
the Arg69 side chain and contacts Trp76. Arg69 makes a second H bond to dU10.
(E) The deoxyribose rings of dU24, dU25, and dG26 make non-polar sugar contacts with Phe7.
(F) A salt bridge is present between the SOMAmer backbone at dU18 and Lys32. Lys32 is sterically constrained by the sugar rings of dU17, dA19, and dC21,
consequently positioning the side chain to form the salt bridge. See also Figure S6 and Table S1.SOMAmer backbone makes a second sharp reversal, allowing
Str3 to form stem II, a triple-stranded interaction with stem I.
The Str3 backbone makes irregular twists and turns, conforming
remarkably well to the NGF surface and forming a topographi-
cally complex recognition domain that sharply contrasts with
the flat plane exhibited by the stem I scaffold (Figure 5A). Str3
residues exhibit the lowest B factors in the structure (not shown),
consistent with close packing of these residues between stem I
and NGF.
NGF Binding Interface
The SOMAmer inserts into a trough at the NGF dimer interface
with Str3 at the apex of the wedge. Binding of each SOMAmer
subunit buries 1,072 A˚2 of solvent-accessible surface area
(SAS) (calculated as ((SASNGF + SASSOMAmer) – SASComplex)/2).
Bn-dU residues play a central role in the interface, accounting
for hydrophobic interactions with 15 amino acids (Table S1).
Several of the natural bases in Str3 also contact NGF, resulting
in almost continuous hydrophobic contact between Str3 and
the protein. Of note, Bn17 sits in a hydrophobic furrow on theStructure 23, 1protein surface, stacking face-to-face with Trp21 and edge-to-
face with Tyr52 (Figure 5B). The Bn-dU17 linker contacts
Phe101, dU17 contacts Ile31, and the deoxyribose ring contacts
the methylene side chain of Lys32 (Figure S6B). Although techni-
cally deriving from Str2, Bn-dU17 does not stack with Str2 bases
in stem I; instead, it projects away from stem I, placing it in close
proximity to the protein (Figures 2B and 5B). The extrusion of Bn-
dU17 from stem I is undoubtedly facilitated by intercalation of
Bn3 between dU16 and dU18, as part of the Bn-dU intercalating
zipper motif (Figure 3B).
Three other modified nucleotides contribute to the NGF bind-
ing interface. Bn24 and Bn25, which contact each other edge-
wise, form a hydrophobic face that complements the hydropho-
bic patch on the protein created by Val18, Val20, and the
methylene side chains of Ser19 and Arg59 (Figure 5C). The
deoxyribose rings of dU24 and dU25make non-polar sugar con-
tacts with Phe7 (Figure 5E). Bn-dU27 exhibits dual functions in
the SOMAmer with the benzyl moiety stabilizing the 30 end as
part of the hydrophobic cluster and the uridine residue contrib-
uting to the protein binding interface; to that end, dU27 stacks293–1304, July 7, 2015 ª2015 Elsevier Ltd All rights reserved 1299
Figure 6. Open-Book View of the NGF-SOMAmer Binding Interface
An electrostatic surface potential rendering of NGF (±5 kT/e) shows the slightly
basic composition of the surface. The SOMAmer interface area is outlined in
yellow on NGF while atoms on the SOMAmer within 4 A˚ of the protein are
colored yellow. The electrostatic surface rendering was prepared in PyMOL
(Delano, 2002) using the APBS plugin (Baker et al., 2001).with Phe12 and contacts Trp76 and the methylene sidechain of
Arg69 (Figure 5D), while the deoxyribose sugar of dU27 contacts
Gly10 and the backbone at Arg114 (Figure S6C). dG26 makes
non-polar contact with Phe7 and Phe12 (Figures 5D and 5E).
A single salt bridge is observed between the SOMAmer back-
bone (at dU18) and Lys32 (Figure 5F). The orientation of Lys32 is
constrained by the sugar rings of dU17, dA19, and dC21, which
together form a hydrophobic channel that cradles the methylene
side chain of the lysine, assisting to position the primary amine to
form the salt bridge with the SOMAmer backbone. Other polar
interactions are limited, with only seven observed H bonds be-
tween the SOMAmer and NGF (Table S1; Figure 5C). Although
the NGF binding surface has a slightly basic composition, the
few H bonds appear to be strategically located to support major
hydrophobic interactions mediated by the aromatic moieties of
the Bn-dU nucleotides (Figure 6). Previously identified RNA ap-
tamers (Binkley et al., 1995; Nakamura et al., 2013) compete
with SL1049 for binding NGF, indicating, at a minimum, partial
overlap in binding sites (data not shown). This result is not sur-
prising given the protein and ligands are of a similar size, and
no general conclusions can be made regarding any similarities
at the nucleotide-residue interface level.
SOMAmer Binding Domain Overlaps Receptor Binding
Epitopes
Binding of NGF to the NGF-specific TrkA receptor was structur-
ally characterized first with TrkA-d5 (Wiesmann et al., 1999) and
subsequently confirmed with a co-crystal structure of the entire
TrkA extracellular domain bound to NGF (Wehrman et al., 2007).
TrkA binds in the saddle formed along the twisted b-sheet core of
the NGF dimer. Binding of each TrkA molecule buries 1,120 A˚2 of
SAS, which is remarkably similar to SOMAmer binding (Figures1300 Structure 23, 1293–1304, July 7, 2015 ª2015 Elsevier Ltd All rig7B and 7C). The NGF residues involved in TrkA binding (Fig-
ure 7A) include a 10 amino acid TrkA specificity region near the
N terminus and a 23 amino acid neurotrophin common patch.
The overall conformation of NGF is similar between the
SOMAmer-bound and TrkA-bound structures (RMS = 0.709,
166 atoms), with the exception of the N-terminal a-helix, which
interacts with both the SOMAmer and TrkA but orients in oppo-
site directions in the structures (Figure S7A). Binding of the
SOMAmer directly overlaps 48% of the TrkA binding residues;
SOMAmer nucleotides Bn-dU17 to Bn-dU25 extensively
occlude the N-terminal portion of the neurotrophin common
binding patch, and the SOMAmer region encompassing nucleo-
tides Bn-dU24 to Bn-dU27 occludes parts of the specificity
patch. Binding of the SOMAmer therefore sterically hinders
TrkA binding (Figures 7B and 7C), consistent with the observa-
tion that the SOMAmer blocks NGF-induced TrkA autophos-
phorylation and neurofilament outgrowth. The aromatic rings of
the Bn-dU-modified nucleotides sometimes appear to mirror
specific receptor-ligand interactions. For example, TrkA
Pro382 stacks face-to-face with NGF Trp21 and edge-to-face
with NGF Tyr52 in much the same way that the SOMAmer
Bn17 interacts with those residues (Figure 7E).
The co-crystal structure of NGF bound to p75NTR reveals that
the receptor binds at the NGF dimer interface, burying 2,300 A˚2
of solvent-accessible surface and contacting NGF primarily in
two hydrophobic regions designated site I and site II (He and
Garcia, 2004). The global conformation of NGF is highly similar
in the SOMAmer-bound and p75NTR-bound structures (RMS =
0.536, 145 atoms) (Figure S7B). SOMAmer binding occludes
half (13/26) of the NGF residues involved in p75NTR binding (Fig-
ure 7A). Given the binding footprints (Figures 7B and 7D) and af-
finity of the SOMAmer, it is highly likely that SOMAmer binding
would block p75NTR binding to NGF. As seen with TrkA, we
observe cases of receptor mimicry by the SOMAmer, where
Bn25 occupies the same position as Tyr83 from p75NTR
(Figure 7F).
DISCUSSION
As one of only three structurally elucidated SOMAmers, the NGF
SOMAmer has greatly advanced our understanding of the struc-
tural vocabulary of these novel ligands. The NGF SOMAmer
shares a number of similarities with the platelet-derived growth
factor (PDGF)-B (Davies et al., 2012) and interleukin-6 (IL-6)
SOMAmers (Gelinas et al., 2014). All three are similar in length
(24–32 nucleotides), the number of modified nucleotides
(8–10), and the size of the protein binding interface (1,097–
1,248 A˚2), which may reflect underlying similarities in starting li-
braries (all Bn-dU modified DNA libraries with 40N random
region) and selection conditions. Compared with traditional ap-
tamers, which rely heavily on polar interactions, these
SOMAmers all utilize remarkably few H bonds and charge-
charge interactions (Davies et al., 2012), instead achieving high
target binding affinity via a primarily hydrophobic protein binding
interface. All three SOMAmers exhibit extensive receptor mim-
icry, resulting in potent inhibition of cytokine-stimulated receptor
activation. Despite these global similarities, the NGF SOMAmer
exhibits several unique features. For example, both the PDGF
and IL-6 SOMAmers exhibit two distinct domains composed ofhts reserved
Figure 7. SOMAmer Binding Occludes Trk-
A and p75NTR Binding Domains on NGF
(A–D) The sequence of the mature form of human
NGF (UniProt: P01138) is shown (A), with residues
involved in receptor interactions indicated: TrkA
specificity patch (teal text), TrkA common patch
(blue text), and p75NTR (bold text) (He and Garcia,
2004; Wehrman et al., 2007; Wiesmann et al.,
1999). Residues involved in SOMAmer binding are
shaded (purple). Comparison of residues on NGF
within 4 A˚ of the SOMAmer (B), purple, TrkA (PDB:
1WWW) (Wiesmann et al., 1999) (C), teal, or p75
(PDB: 1SG1) (He and Garcia, 2004) (D), green.
(E) Superposition of the NGF from the SOMAmer
structure (gold) and PDB: 1WWW (light teal) shows
TrkA residue Pro382 (teal) and SOMAmer Bn-
dU17 (light purple) occupying the same position
and interacting with NGF residues Trp21 and
Tyr52.
(F) Superposition of NGF from the SOMAmer
structure (gold) and PDB: 1SG1 (light green)
shows p75NTR residue Tyr83 (green) and
SOMAmer-modified nucleotides Bn-dU24 and
Bn-dU25 (purple) occupying similar positions at
the binding interface. See also Figure S7.known nucleic acid structural elements such as stem loops,
pseudoknots, and G-quartets. In contrast, the NGF SOMAmer
assumes a single compact S-shaped structure containing an in-
tercalating zipper at one end and a Bn-dU cluster at the other
end, flanking a non-helical triple-stranded core. Whereas the
PDGF and IL-6 SOMAmers rely primarily on canonical base pair-
ing, the NGF SOMAmer makes extensive use of Hoogsteen and
sugar edge interactions, engaging virtually every available
H-bond donor and acceptor in a network of base triples and qua-
druples. In the PDGF and IL-6 SOMAmers, the modified nucleo-
tide side chains reside almost exclusively at the protein binding
interface; conversely, the modified nucleotides play a more
prominent role in the internal structure of the NGF SOMAmer
with fewer side chains contributing directly to the protein binding
interface. The unusual conformation of the NGF SOMAmer posi-
tions the extra aromatic rings of the modified nucleotides to
maximize intramolecular p-stacking, thus stabilizing an entirely
novel configuration of non-canonical base pairs and uncommon
glycosidic bond angles.
We have identified two unique intramolecular structural motifs
formed by Bn-dU residues: the intercalating zipper and the clus-
ter. Upon closer inspection, the zipper and the cluster can be
viewed as variants of the same structural motif, each consisting
of three Bn-dU residues that exhibit certain hallmark character-Structure 23, 1293–1304, July 7, 2015 ªistics. These include (1) reciprocal stack-
ing of benzyl and uridyl rings from two
Bn-dU residues arising from opposite
strands, forming the teeth of the zipper,
and (2) an adjacent Bn-dU adopting an
L-shape that facilitates face-to-face
stacking of its uridine with the teeth of
the zipper and edge-to-face stacking of
its benzyl group with one of the benzyl
teeth. Despite the underlying similaritybetween the two motifs, the differences between the motifs are
equally notable. Whereas the zipper represents an entirely inter-
nal structural element that stabilizes the nucleic acid scaffold,
the cluster contributes significantly (albeit indirectly) to the pro-
tein interface in addition to its structural role. The aromatic rings
in the cluster participate in a more extensive network of intermo-
lecular and intramolecular p-stacking interactions than seen in
the zipper motif. These differences exemplify the exceptional
range of conformations that are accessible as a result of the rota-
tional freedom afforded by the Bn-dU linker. In view of these ob-
servations, it is not surprising that all of the modified nucleotides,
with the exception of Bn-dU18, contribute substantially to NGF
binding affinity; single substitution of deoxythymidine (dT) for
Bn-dU at any of these positions results in marked loss of affinity.
The triple-stranded SOMAmer core bears little resemblance to
any of the three major subtypes of DNA triple helices that have
been described. In typical DNA triple-helical structures, a WC
duplex containing an oligopurine strand (R strand) and an oligo-
pyrimidine strand (Y strand) pairs with a third strand via the
Hoogsteen face of the R strand in the major groove of the duplex
(Duca et al., 2008). Only one base triple in the SOMAmer fits the
pattern of an antiparallel GT triplex motif: WC base pairing be-
tween dG15 and dC21 and a reverse Hoogsteen base pair be-
tween dG15 and dG4. Beyond that, any similarity to known2015 Elsevier Ltd All rights reserved 1301
triplex motifs breaks down since the SOMAmer lacks an
extended WC duplex or any semblance of helicity. In traditional
DNA triple helices, the backbones of the R and third strands are
in close proximity, bringing negatively charged atoms less than
6 A˚ apart. Unfavorable charge repulsion thus destabilizes the
triplex structure and supra-physiological levels of divalent or pol-
ycationic agents are necessary to stabilize the triplex (Duca et al.,
2008). Although the SOMAmer backbone comes in close prox-
imity at one point in stem I, with 6 A˚ between the non-bridging
oxygens of dA5 and dG14, in general the non-helical triangular
prism configuration of the SOMAmermaintains a greater separa-
tion of charge than typically seen in triple-helical DNA. Thus, the
unusual base triples at the central core are likely a contributing
factor to the observed absence of helicity in this structure. This
feature is also consistent with the observation that the SOMAmer
does not require divalent cations for NGF binding. These unique
motifs almost certainly contribute thermodynamic stability to the
structure, driving the SOMAmer to adopt unconventional base
conformations and non-canonical base pairing in order to fold
into a maximally stacked and highly compact structure.
Pi stacking interactions reminiscent of the SOMAmer zipper
motif are also observed in traditional DNA/RNA aptamer pro-
tein structures (Cheung et al., 2013; Convery et al., 1998;
Huang et al., 2003, 2009; Nomura et al., 2010; Russo Krauss
et al., 2011), where an extruded base interacts with a side
chain on the protein. Unlike SOMAmers, the expelled nucleo-
tides are disengaged from the primary DNA/RNA structure,
exhibiting few if any intramolecular interactions, but like the
SOMAmers, the extrusion appears to be necessary, not only
for interactions with the target but to accommodate tight turns
or other aspects of the folded structure. In addition to p-stack-
ing, the extruded nucleotides of the traditional aptamers are
often positioned to participate in a number of H bonds with
the protein, which are noticeably sparse in SOMAmer struc-
tures (Davies et al., 2012).
SOMAmers embody the intersection between evolutionary
biology and synthetic chemistry. Combining the evolutionary po-
wer of SELEX with the enhanced shape and functional group di-
versity afforded by chemically modified nucleotide libraries has
opened the door to a whole new class of molecules.
SOMAmer-target co-crystal structures provide a startling
glimpse into the rich and varied structures that emerge from
chemically enhanced SELEX libraries. The insights afforded by
the NGF structure provide inspiration for further chemical modi-
fications aimed at refining the interface area. We have shown
that many different C5-linked modifications of deoxyuridine are
compatible with SELEX (Davies et al., 2012; Gelinas et al.,
2014; Vaught et al., 2010) and each has the potential to impart
unique characteristics. Different chemical modifications lead to
intrinsic variations in SOMAmer specificity and affinity, as well
as nuclease resistance (Gupta et al., 2014). The ability to fine-
tune the physico-chemical properties of the SOMAmer can facil-
itate the selection of molecules with optimal characteristics for
diagnostic and therapeutic applications.EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for additional experimental
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NGF SOMAmers were discovered by using biotinylated recombinant human
NGF in the SELEX with a kinetic challenge step, as described previously
(Gold et al., 2010). The DNA library comprised 40 random positions with
Bn-dU replacing dT in the random region. Selections were performed in
SB17T buffer (40 mM HEPES [pH 7.5], 102 mM NaCl, 5 mM KCl, 5 mM
MgCl2, 1 mM EDTA, 0.05% TWEEN 20). Bn-dU SOMAmers were synthesized
by solid phase synthesis using the phosphoramidite method (Beaucage and
Caruthers, 1981),withmodifieddeoxyuridine-5-carboxamideamidite reagents,
as described previously (Davies et al., 2012; Gupta et al., 2014).
Measurement of Equilibrium Binding Constant
Equilibrium binding constants (Kd) of SOMAmers were measured in SB18T
buffer (SB17 buffer with no EDTA, 0.01% TWEEN 20) at 37C as described
previously Gold et al., 2010). Briefly, heat-cooled radiolabeled SOMAmer
was equilibrated for 17 hr (to ensure equilibrium was reached) with different
concentrations of NGF and NGF-SOMAmer complexes, captured with
ZORBAX PSM-300 resin, and quantified with a phosphorimager. The fraction
of captured SOMAmer was plotted as a function of NGF concentration and the
data were fit to a three-parameter sigmoid dose-response model to determine
a Kd value.
Measurement of the Association Rate Constant (kon)
NGFat variousconcentrations (0.32–32nM)was incubatedwithheat-cooled ra-
diolabeledSOMAmer at 37C. Aliquotswere removed at various times between
0 and 1,050 s and complexeswere isolated and quantified as described above.
For each data point, the fraction of SOMAmer bound to NGFwas normalized to
thevalueat 1,050 swith32nMNGF.Relative fractionboundvalueswereplotted
as a function of time and the data were fit to a one-phase association model to
determine theapparent association rate constant (kon
app) for eachNGFconcen-
tration.Aplot of (kon
app) as a functionofNGFconcentration showeda linear rela-
tionship with a slope equal to the association rate constant (kon).
Measurement of the Dissociation Rate Constant (koff)
NGF (1 3 108 M) was incubated with heat-cooled radiolabeled SOMAmer at
37C for 30min. After adding unlabeled SOMAmer at the final concentration of
1 3 107 M, aliquots were removed at various times between 0 and 360 min.
Complexes were isolated, quantified, and normalized to the value at t = 0 as
described above. Relative fraction bound values were plotted as a function
of time and the data were fit to a one-phase dissociation model to determine
the koff value.
Serum Stability Assay
Heat-cooled SOMAmer (500 nM) was incubated with 90% fresh human serum
at 37C. Aliquots were removed at various time points from 0 to 72 hr, ex-
tracted with phenol and chloroform, and analyzed by denaturing PAGE, as
described previously (Gupta et al., 2014). DNA stained with SYBR gold was
imaged with a fluorescent image analyzer (FUJI FLA-3000) and quantified us-
ing the ImageGauge software package to determine the fraction of intact
SOMAmer at each time point.
Thermal Stability Analysis
Thermal melt studies were performed in SB18T buffer as described previously
(Davies et al., 2012). Because baselines were not easily determined, Tm values
were estimated using the maximum of first derivative method (Mergny and La-
croix, 2003). Derivatives were calculated as five-point tangential slopes at
each temperature.
TrkA Phosphorylation Assay
PC12 cells (rat pheochromocytoma, ATCC) were seeded on 100-mm collagen
IV coated plates (BD Bioscience). After overnight attachment, low serum me-
dium (LSM) was added (0.2% FBS, 0.1% horse serum, 10 U/ml penicillin,
10 mg/ml streptomycin/RPMI-1640). The cells were left in LSM overnight and
were then treated for 10 min with NGF alone (10 ng/ml, or 0.38 nM), NGF
with TrkA phosphorylation inhibitor K252a (0.2 mM), and NGF pre-equilibrated
with 10 nM SOMAmer. Cells were lysed in RIPA lysis buffer supplemented with
PMSF, protease inhibitor cocktail, and sodium orthovanadate (Santa Cruz
Biotechnology). The protein concentration in the lysates was measured byhts reserved
DC protein assay (Bio-Rad). Aliquots of the lysates with equal amounts of pro-
tein were immuno-precipitated with an anti-Trk antibody C-14 (Santa Cruz
Biotechnology) for 1 hr at 4C. The precipitated proteins were purified using
Protein A Sepharose Fast Flow (GE Healthcare). The immuno-precipitate
was run on an SDS-PAGE gel, transferred to a polyvinylidene fluoride mem-
brane, and probed with anti-phospho-tyrosine antibody 4G10 (Millipore) to
quantify the amount of phosphorylated TrkA. The blot was stripped and
probed with anti-Trk antibody C-14 to quantify the amount of total TrkA.
Immuno-reactive bands were detected using an ECL Plus Western Blotting
Detection System (GE Healthcare). Percent TrkA phosphorylation (ratio of
phosphorylated TrkA/total TrkA) was normalized to a control obtained in the
absence of added oligonucleotides.
Neurite Outgrowth Inhibition Assay
PC12 cells were seeded on 60-mm dishes at a density of 1.5 3 105 cells per
dish. After 24 hr, the medium was replaced with LSM to induce differentiation.
NGF (100 ng/ml or 3.8 nM) was mixed with SOMAmer (100 nM) for 1 hr, then
added to the plates to final concentrations of 10 ng/ml NGF (0.38 nM) and
10 nMSOMAmer. After 3 days, fresh mediumwith NGF-SOMAmer complexes
was added. On day 5, images of the cells were captured with a phase-contrast
microscope and neurite length wasmeasured using the NeuronJ plugin for Im-
ageJ (NIH program). Neurite length/cell was calculated and normalized to a
value of 100 observed in the absence of added oligonucleotides.
Crystallization and Heavy Atom Soaking
The complex of SL1049 and recombinant human NGF (Creative Biomart, CHO
cell expression) was crystallized at 16C by combining 0.4 ml of protein-
SOMAmer complex (0.33 mM in PBS buffer) with 0.4 ml of crystallization solu-
tion (14–16 % PEG 8000, 100 mM HEPES [pH 6.0], 100 mM magnesium
acetate, and 20% glycerol) in a sitting drop vapor diffusion tray (Compact
300 96-well crystallization plates, Rigaku Reagents). Sodium iodide was
used for the heavy atom soak for phasing.
Data Collection and Structure Determination
A 2.45-A˚ native dataset was collected at the Canadian Light Source synchro-
tron. The NGF structure could be solved by molecular replacement but the
solution did not provide enough phasing power to build the SOMAmer in the
resulting electron density. Therefore, the technique of single anomalous
dispersion (SAD) was used from a crystal soaked in an iodide salt (Abendroth
et al., 2011; Dauter and Dauter, 2007; Dauter et al., 2000). This resulting low-
resolution dataset (3.15 A˚) was solved using the NGF portion of PDB: 1WWW.
Four iodide sites were found and used for SAD phasing and combined with
phases from the molecular replacement solution using the program PHASER
in the CCP4 software suite in ‘‘experimental phasing’’ mode (McCoy et al.,
2007; Winn et al., 2011).
The electron density from the phased data was modified using the program
Parrot. The resulting maps showed features consistent with nucleic acid but
identifying sequence position or even chain polarity was difficult. As an inter-
mediate step, 16 phosphate ions were modeled into the strongest peaks of
the putative DNA density. The expanded partial model was then used for
another round of SAD with model phasing. The map quality improved suffi-
ciently to allow modeling of four nucleotide residues in each subunit. Another
round of phasing resulted in incrementally improved maps again. The
expanded model (NGF plus eight nucleotide residues plus dummy phos-
phates) was then carried into the 2.45-A˚ native dataset. The iodide atoms
were removed from the model and restrained refinement using Refmac (Vagin
et al., 2004) was carried out. The resulting data were subjected to density
modification using Parrot. The modified maps were a significant improvement
over the low-resolution maps and model building was completed by boot-
strapping using maps generated from the 2.45-A˚ data. All nucleotide residues
in the final model were manually placed in the electron density maps and the
final maps were of sufficient quality to allow unambiguous placement of the
nucleoside bases and modifications.
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